Brodsky & Smith LLC has announced investigations into whether the boards of Esperion Therapeutics, Sila Realty Trust, Lisata Therapeutics, and SkyWater Technology breached their fiduciary duties to shareholders during recent merger agreements. The investigations focus on whether these boards conducted fair processes and offered fair value to shareholders in the deals. These mergers involve cash and stock transactions with values ranging from $3.16 to $35 per share. Investors holding shares in these companies are encouraged to contact Brodsky & Smith for more information, with no cost or obligation involved.
Alstom and its consortium partners have reached financial close for the Haifa-Nazareth light rail project in Israel, a major step enabling full-scale execution. The €2 billion project will build a 41-kilometer light rail line connecting Haifa, Nazare...
Alstom and its partners have finalized financing for the Haifa-Nazareth light rail project in Israel, valued at around €2 billion, with Alstom's share at approximately €750 million. The 41-kilometer line will connect Haifa, Nazareth, and nearby commu...
The global strategy consulting market, valued at $81.51 billion in 2025, is projected to grow to $194.56 billion by 2035 with a CAGR of 9.09%. Growth is fueled by increasing demand for digital transformation, AI-powered advisory services, ESG consult...
The global pharmaceutical surfactants market, valued at $4.5 billion in 2025, is projected to grow to $6.93 billion by 2035 at a CAGR of 4.42%. Growth is fueled by increasing use in drug formulation to enhance solubility, stability, and bioavailabili...
Bitcoin has rebounded from its Asian session lows, trading around $63,500 despite a nearly 3% drop over the past 24 hours. This recovery comes as Nasdaq futures fell to their lowest level since May, down 1.2% for the week, with significant declines i...
